IRIS
MIKULSKA, MALGORZATA KAROLINA
 Distribuzione geografica
Salva come PNG Salva come JPEG
Continente #
EU - Europa 19.940
AS - Asia 3.202
NA - Nord America 2.815
Continente sconosciuto - Info sul continente non disponibili 590
SA - Sud America 265
AF - Africa 63
OC - Oceania 4
Totale 26.879
Salva come PNG Salva come JPEG
Nazione #
IT - Italia 19.440
US - Stati Uniti d'America 2.636
SG - Singapore 1.157
CN - Cina 734
VN - Vietnam 554
BD - Bangladesh 442
FR - Francia 188
BR - Brasile 152
HK - Hong Kong 92
CA - Canada 79
DE - Germania 67
AR - Argentina 48
FI - Finlandia 48
GB - Regno Unito 34
IN - India 34
JP - Giappone 34
MX - Messico 30
NL - Olanda 30
IQ - Iraq 25
JM - Giamaica 18
EC - Ecuador 17
UA - Ucraina 17
ID - Indonesia 16
ZA - Sudafrica 14
CH - Svizzera 13
CO - Colombia 13
CR - Costa Rica 13
ES - Italia 13
PK - Pakistan 12
PH - Filippine 11
RU - Federazione Russa 11
TH - Thailandia 11
TR - Turchia 10
UZ - Uzbekistan 10
DZ - Algeria 9
KR - Corea 9
VE - Venezuela 9
AT - Austria 8
GR - Grecia 8
PY - Paraguay 8
ET - Etiopia 7
KE - Kenya 7
PL - Polonia 7
SA - Arabia Saudita 7
SV - El Salvador 7
TT - Trinidad e Tobago 7
AE - Emirati Arabi Uniti 6
CL - Cile 6
EG - Egitto 6
NP - Nepal 6
PE - Perù 6
PT - Portogallo 6
SE - Svezia 6
AL - Albania 5
BB - Barbados 5
TW - Taiwan 5
AU - Australia 4
BG - Bulgaria 4
DO - Repubblica Dominicana 4
IE - Irlanda 4
JO - Giordania 4
LT - Lituania 4
MA - Marocco 4
UY - Uruguay 4
BH - Bahrain 3
GT - Guatemala 3
KZ - Kazakistan 3
MT - Malta 3
NO - Norvegia 3
PR - Porto Rico 3
RS - Serbia 3
SK - Slovacchia (Repubblica Slovacca) 3
SY - Repubblica araba siriana 3
BE - Belgio 2
BO - Bolivia 2
CI - Costa d'Avorio 2
CZ - Repubblica Ceca 2
GA - Gabon 2
HN - Honduras 2
HR - Croazia 2
HU - Ungheria 2
IR - Iran 2
KG - Kirghizistan 2
KY - Cayman, isole 2
LB - Libano 2
MK - Macedonia 2
MY - Malesia 2
NI - Nicaragua 2
PA - Panama 2
PS - Palestinian Territory 2
RO - Romania 2
AG - Antigua e Barbuda 1
AI - Anguilla 1
AO - Angola 1
BF - Burkina Faso 1
BJ - Benin 1
BW - Botswana 1
CW - ???statistics.table.value.countryCode.CW??? 1
DK - Danimarca 1
GE - Georgia 1
Totale 26.277
Salva come PNG Salva come JPEG
Città #
Genova 8.772
Genoa 6.741
Vado Ligure 1.721
Rapallo 1.605
Singapore 575
San Jose 564
Ashburn 314
Ho Chi Minh City 173
New York 173
Lauterbourg 165
Beijing 158
Hanoi 139
Council Bluffs 125
Hong Kong 85
Bordighera 77
Santa Clara 73
Milan 66
Los Angeles 62
Frankfurt am Main 52
Buffalo 48
Rome 40
Helsinki 39
Chicago 35
Dallas 29
Haiphong 29
Tokyo 28
Boardman 27
Da Nang 23
Houston 22
Naples 18
Bologna 17
Phoenix 17
Orem 16
St Louis 15
Toronto 15
Atlanta 14
Biên Hòa 14
Florence 14
São Paulo 14
Amsterdam 13
Montreal 13
Philadelphia 13
Turin 13
Mexico City 12
London 11
Miano 11
Zurich 11
Las Vegas 10
Miami 10
Modena 10
San Francisco 10
Verona 10
Baghdad 9
Bar Harbor 9
City of London 9
Dhaka 9
Hải Dương 9
Kingston 9
Kyiv 9
Lappeenranta 9
San José 9
The Bronx 9
Tianjin 9
Can Tho 8
Denver 8
Minneapolis 8
Queens 8
Tampa 8
Tashkent 8
Addis Ababa 7
Austin 7
Bari 7
Catania 7
Charlotte 7
Fort Wayne 7
Madrid 7
Marseille 7
Palermo 7
Paris 7
Quito 7
San Antonio 7
Bangkok 6
Brooklyn 6
Colorado Springs 6
Columbus 6
Guangzhou 6
Lima 6
Louisville 6
Nairobi 6
New Orleans 6
San Salvador 6
Thái Nguyên 6
Venice 6
Warsaw 6
Athens 5
Birmingham 5
Bra 5
Bridgetown 5
Buenos Aires 5
Bắc Ninh 5
Totale 22.600
Salva come PNG Salva come JPEG
Nome #
Clinical characteristics, management and in-hospital mortality of patients with COVID-19 In Genoa, Italy 345
Bench-to-bedside review: therapeutic management of invasive candidiasis in the intensive care unit 251
Initial serum (1,3)-β-d-glucan as a predictor of mortality in proven candidaemia: findings from a retrospective study in two teaching hospitals in Italy and Brazil 245
Case report: management and HBV sequencing in a patient co-infected with HBV and HIV failing tenofovir. 234
Use of Cefiderocol in Adult Patients: Descriptive Analysis from a Prospective, Multicenter, Cohort Study 230
Primary prophylaxis of invasive fungal diseases in allogeneic stem cell transplantation: revised recommendations from a consensus process by Gruppo Italiano Trapianto Midollo Osseo (GITMO). 217
Candida auris Candidemia in Critically Ill, Colonized Patients: Cumulative Incidence and Risk Factors 208
Effectiveness of a project to prevent HIV vertical transmission in the Republic of Congo. 202
Use of colistin in adult patients: a cross-sectional study 202
External validation of unsupervised COVID-19 clinical phenotypes and their prognostic impact 198
Bacterial infections in hematopoietic stem cell transplantation recipients. 198
Bronchoalveolar lavage fluid characteristics and outcomes of invasively mechanically ventilated patients with COVID-19 pneumonia in Genoa, Italy 196
Prevalence and prognostic value of cardiac troponin in elderly patients hospitalized for COVID-19 193
Impact of a mixed educational and semi-restrictive antimicrobial stewardship project in a large teaching hospital in Northern Italy 191
Pneumocystis jirovecii pneumonia in intensive care units: a multicenter study by ESGCIP and EFISG 188
Bacterial infections in hematopoietic stem cell transplant recipients 184
Prevalence and Clinical Significance of Persistent Viral Shedding in Hospitalized Adult Patients with SARS-CoV-2 Infection: A Prospective Observational Study 182
Combined use of serum (1,3)-β-d-glucan and procalcitonin for the early differential diagnosis between candidaemia and bacteraemia in intensive care units 181
Pre-Engraftment Bloodstream Infections after Allogeneic Hematopoietic Cell Transplantation: Impact of T Cell-Replete Transplantation from a Haploidentical Donor 180
ESCMID Study Group for Infections in Compromised Hosts (ESGICH) Consensus Document on the safety of targeted and biological therapies: an Infectious Diseases perspective (Agents targeting lymphoid cells surface antigens [I]: CD19, CD20 and CD52) 180
Bloodstream infections in critically ill patients with COVID-19 180
Efficacy of lamivudine prophylaxis in preventing hepatitis B virus reactivation in patients with resolved infection undergoing allogeneic SCT and receiving rituximab 179
Biomarkers for Diagnosis and Follow-Up of Invasive Candidiasis: A Brief Review of the ECIL Recommendations 178
Desirability of outcome ranking (DOOR) for comparing diagnostic tools and early therapeutic choices in patients with suspected candidemia 178
Hepatitis B reactivation in HBsAg-negative/HBcAb-positive allogeneic haematopoietic stem cell transplant recipients: risk factors and outcome. 177
Lower sensitivity of serum (1,3)-β-D-glucan for the diagnosis of candidaemia due to Candida parapsilosis 177
Non-cultural methods for the diagnosis of invasive fungal disease 175
Invasive candidiasis in non-hematological patients. 174
De-Escalation and Discontinuation of Empirical Antibiotic Treatment in a Cohort of Allogeneic Hematopoietic Stem Cell Transplantation Recipients during the Pre-Engraftment Period 173
Invasive pulmonary aspergillosis in intensive care units: is it a real problem? 172
Performance of serum (1,3)-ß-d-glucan screening for the diagnosis of invasive aspergillosis in neutropenic patients with haematological malignancies 172
Clinical characteristics, management and in-hospital mortality of patients with coronavirus disease 2019 in Genoa, Italy 172
European guidelines for empirical antibacterial therapy for febrile neutropenic patients in the era of growing resistance: summary of the 2011 4th European Conference on Infections in Leukemia. 168
Invasive mycoses in children receiving hemopoietic SCT 168
(1-3)-β-d-glucan in cerebrospinal fluid is useful for the diagnosis of central nervous system fungal infections. 168
Multidrug-resistant bacteria in hematology patients: Emerging threats 167
Aetiology and resistance in bacteraemias among adult and paediatric haematology and cancer patients. 167
Bloodstream infections in neutropenic cancer patients: A practical update 166
Pulmonary cryptococcosis with severe eosinophilia in an immunocompetent patient. 165
Pathogens in Severe Sepsis: New Paradigms for Fungi Treatment 160
Will new antimicrobials overcome resistance among Gram-negatives? 159
Galactomannan: testing the same sample twice? 159
Piperacillin/tazobactam (TazocinTM) seems to be no longer responsible forfalse-positive results of the galactomannan assay 156
Occurrence, presentation and treatment of candidemia. 155
Epidemiology of viral respiratory tract infections in an outpatient haematology facility 154
Clinical performance of the (1,3)-β-D-glucan assay in early diagnosis of nosocomial Candida bloodstream infections. 153
Tocilizumab and steroid treatment in patients with COVID-19 pneumonia 153
The use of mannan antigen and anti-mannan antibodies in the diagnosis of invasive candidiasis: recommendations from the Third European Conference on Infections in Leukemia. 152
Risk factors for severe complications of the novel influenza A (H1N1): analysis of patients hospitalized in Italy. 152
Correction to: Impact of a mixed educational and semi-restrictive antimicrobial stewardship project in a large teaching hospital in Northern Italy (Infection, 10.1007/s15010-017-1063-7) 152
Blood stream infections in allogeneic hematopoietic stem cell transplant recipients: reemergence of Gram-negative rods and increasing antibiotic resistance. 150
Serum sickness (Like Reaction) in a patient treated with alemtuzumab for multiple sclerosis: A case report 150
Visceral leishmaniasis in hematopoietic cell transplantation: Case report and review of the literature 150
Towards the automatic calculation of the EQUAL Candida Score: Extraction of CVC-related information from EMRs of critically ill patients with candidemia in Intensive Care Units 150
Galactomannan testing might be useful for early diagnosis of fusariosis. 149
2017 ECIL 7 vaccine guidelines 149
Voriconazole in clinical practice. 148
Extensive activation, tissue trafficking, turnover and functional impairment of NK cells in COVID-19 patients at disease onset associates with subsequent disease severity 148
Current and emerging pharmacotherapy for the treatment of infections following open-heart surgery 146
Mortality after bloodstream infections in allogeneichaematopoietic stem cell transplant (HSCT) recipients 145
The Beta-d-glucan Test: Time to Re-Visit Its Utility in IFI Diagnosis 145
Serial monitoring of isavuconazole blood levels during prolonged antifungal therapy 145
The role of televancin in the treatment of MRSA infections in hospital 144
ECILrecommendations for the use of biological markers for the diagnosis of invasivefungal diseases in leukemic patients and hematopoietic SCT recipients 144
Vaccination of patients with haematological malignancies who did not have transplantations: guidelines from the 2017 European Conference on Infections in Leukaemia (ECIL 7) 144
Impact of antibiotic resistance on outcomes of neutropenic cancer patients with Pseudomonas aeruginosa bacteraemia (IRONIC study): Study protocol of a retrospective multicentre international study 143
Ocrelizumab does not impair B- and T-cell responses to primary VZV infection in a patient with MS 143
Screening With Serum Galactomannan Might Be Associated With Better Outcome Than Symptom-Triggered Galactomannan Testing in Allogeneic HSCT Recipients With Invasive Aspergillosis. 142
ESCMID Study Group for Infections in Compromised Hosts (ESGICH) Consensus Document on the safety of targeted and biological therapies: an infectious diseases perspective (Agents targeting lymphoid or myeloid cells surface antigens [II]: CD22, CD30, CD33, CD38, CD40, SLAMF-7 and CCR4) 142
Aspergillus-PCR in bronchoalveolar lavage - diagnostic accuracy for invasive pulmonary aspergillosis in critically ill patients 141
SIMIFF study: Italian fungal registry of mold infections in hematological and non-hematological patients. 141
Aggressive multiple sclerosis: a single-centre, real-world treatment experience with autologous haematopoietic stem cell transplantation and alemtuzumab 141
CMV infection after transplant from cord blood compared to other alternative donors: the importance of donor-negative CMV serostatus. 141
Targeted therapy against multi-resistant bacteria in leukemic and hematopoietic stem cell transplant recipients: guidelines of the 4th European Conference on Infections in Leukemia (ECIL-4, 2011). 140
Diagnostic and therapeutic approach to infectious diseases in solid organ transplant recipients 140
La Definizione di Aspergillosi 137
Evaluation of mass spectrometry-based detection of panfungal serum disaccharide for diagnosis of invasive fungal infections: Results from a collaborative study involving six European clinical centers 137
Efficacy of daptomycin lock therapy in the treatment of bloodstream infections related to long-term catheter. 136
ECIL guidelines for preventing Pneumocystis jirovecii pneumonia in patients with haematological malignancies and stem cell transplant recipients 136
Current research in empirical therapy for febrile neutropenia in cancer patients: what should be necessary and what is going on. 135
Discontinuation of empirical antibiotic therapy in neutropenic leukaemia patients with fever of unknown origin is ethical 135
Invasive aspergillosis: diagnosis, prophylaxis and treatment 134
Outbreak of Ralstonia pickettii bacteraemia in patients with haematological malignancies and haematopoietic stem cell transplant recipients 134
Comparable survival using a CMV-matched or a mismatched donor for CMV+ patients undergoing T-replete haplo-HSCT with PT-Cy for acute leukemia: a study of behalf of the infectious diseases and acute leukemia working parties of the EBMT 134
The skin and soft tissue infections in hematological patients 134
Manuale per la gestione delle complicanze infettive nell’emato-oncologia e trapianto di midollo osseo 132
The prognostic impact of the cytomegalovirus serostatus in patients with chronic hematological malignancies after allogeneic hematopoietic stem cell transplantation: a report from the Infectious Diseases Working Party of EBMT 132
Management of chronic viral hepatitis in the hematological patient 131
Antimicrobial Resistance in Gram-Negative Rods Causing Bacteremia in Hematopoietic Stem Cell Transplant Recipients: Intercontinental Prospective Study of the Infectious Diseases Working Party of the European Bone Marrow Transplantation Group 130
Enterococcal bloodstream infection after hematopoietic stem cell transplant: experience of a center with a low prevalence of vancomycin-resistant enterococci. 130
Recommendations for screening, monitoring, prevention, prophylaxis and therapy of hepatitis B virus reactivation in patients with haematologic malignancies and patients who underwent haematologic stem cell transplantation—a position paper 128
A Response to: Letter to the Editor Regarding Management of Adult Patients with COVID-19 Outside Intensive Care Units: Guidelines from the Italian Society of Anti-Infective Therapy (SITA) and the Italian Society of Pulmonology (SIP) 128
Fluoroquinolone prophylaxis in haematological cancer patients with neutropenia: ECIL critical appraisal of previous guidelines 127
Fluoroquinolone prophylaxis during neutropenia: what can we expect nowadays? 127
Short Course of Antifungal Therapy in Patients With Uncomplicated Candida Bloodstream Infection: Another Case of Less Is More in the Clinical Setting? 126
Vaccination of haemopoietic stem cell transplant recipients: guidelines of the 2017 European Conference on Infections in Leukaemia (ECIL 7) 126
Risk factors for invasive aspergillosis and related mortality in recipients of allogeneic SCT from alternative donors: an analysis of 306 patients 125
Incidence and Prognosis of Ventilator-Associated Pneumonia in Critically Ill Patients with COVID-19: A Multicenter Study 125
Validation of an Automated System for the Extraction of a Wide Dataset for Clinical Studies Aimed at Improving the Early Diagnosis of Candidemia 124
Risk factors for enterococcal bacteremia in allogeneic hematopoietic stem cell transplant recipients. 124
Totale 16.074
Salva come PNG Salva come JPEG
Categoria #
all - tutte 95.146
article - articoli 92.419
book - libri 400
conference - conferenze 0
curatela - curatele 0
other - altro 0
patent - brevetti 0
selected - selezionate 0
volume - volumi 2.327
Totale 190.292
Salva come PNG Salva come JPEG


Totale Lug Ago Sett Ott Nov Dic Gen Feb Mar Apr Mag Giu
2021/20221.741 67 48 101 233 75 168 77 414 86 179 70 223
2022/20232.076 194 139 27 181 263 285 72 138 303 132 278 64
2023/20241.477 81 168 55 189 158 217 83 107 71 47 119 182
2024/20254.357 100 324 107 304 595 426 414 733 212 219 453 470
2025/20269.017 943 307 626 706 1.030 577 1.181 478 730 829 743 867
2026/2027887 887 0 0 0 0 0 0 0 0 0 0 0
Totale 26.879